Iqvia reports Q3 EPS $2.84, consensus $2.81

Reports Q3 revenue $3.9B, consensus $3.86B…”IQVIA (IQV) reported strong third quarter results,” stated Ari Bousbib, chairman and CEO of IQVIA. “We delivered margin expansion, strong free cash flow, and double-digit Adjusted Diluted EPS growth. As we anticipated, TAS revenue growth accelerated in the quarter; in fact, revenue growth exceeded our expectations to over 8 percent year-over-year, underlining our confidence in the continued recovery of this segment. R&DS revenue growth achieved our expectations, even as our short-term outlook has been affected by the combined impact of one large program cancellation and the delay of two mega trials. The R&DS business fundamentals are solid as forward-looking indicators such as RFP flow, qualified pipeline growth, backlog growth, and next-twelve-month revenue from backlog remain healthy.”